三年后的PROGRESS试验：是时候进行一份关于疗效的平衡报告了。
The PROGRESS trial three years later: time for a balanced report of effectiveness.
作者信息
Wennberg Richard, Zimmermann Camilla
机构信息
Department of Medicine, University of Toronto, University Health Network, Toronto, ON, Canada M5T 2S8.
出版信息
BMJ. 2004 Oct 23;329(7472):968-70. doi: 10.1136/bmj.329.7472.968.
Abstract
Has the use of the phrase “perindopril based blood pressure lowering regimen” resulted in an oversimplistic and hence inaccurate interpretation of the results of the PROGRESS trial creeping into the literature and clinical practice?
摘要
“培哚普利降压方案”这一表述的使用是否导致了对PROGRESS试验结果过于简单化从而不准确的解读渗入到文献和临床实践中？
相似文献
1
The PROGRESS trial three years later: time for a balanced report of effectiveness.三年后的PROGRESS试验：是时候进行一份关于疗效的平衡报告了。
BMJ. 2004 Oct 23;329(7472):968-70. doi: 10.1136/bmj.329.7472.968.
2
The PROGRESS trial three years later: time for more action, less distraction.三年后的PROGRESS试验：是时候采取更多行动、减少干扰了。
BMJ. 2004 Oct 23;329(7472):970-1. doi: 10.1136/bmj.329.7472.970.
3
[Efficacy of a converting enzyme inhibitor in the prevention of recurrence of stroke].
Presse Med. 2001 Nov 24;30(35):1716-7.
4
[Clinical efficacy of noliprel in the treatment of hypertension. Main results of ETALON].
Kardiologiia. 2004;44(3):66-9.
5
Combination BP therapy cuts second stroke risk in half.
Geriatrics. 2001 Aug;56(8):14, 16.
6
Invited commentary. Stroke preventive treatment using perindopril and indapamide in the context of Indian primary care.
Neurol India. 2007 Apr-Jun;55(2):101-2. doi: 10.4103/0028-3886.32765.
7
Incidence of recurrent stroke in primary care during preventive treatment based on perindopril with or without indapamide.基于培哚普利联合或不联合吲达帕胺进行预防性治疗期间，初级保健中复发性中风的发生率。
Neurol India. 2007 Apr-Jun;55(2):141-4. doi: 10.4103/0028-3886.32785.
8
You should treat patients over the age of 80 who have hypertension.你应该治疗80岁以上患有高血压的患者。
Medscape J Med. 2008;10(8):185. Epub 2008 Aug 7.
9
Blood pressure reduction and ACE inhibition in secondary stroke prevention: mechanism uncertain.二级卒中预防中的血压降低与血管紧张素转换酶抑制：机制尚不确定。
Stroke. 2003 May;34(5):1335-6. doi: 10.1161/01.STR.0000069265.51001.D8. Epub 2003 Apr 17.
10
Effects of a perindopril-based blood pressure-lowering regimen on the risk of recurrent stroke according to stroke subtype and medical history: the PROGRESS Trial.根据中风亚型和病史，培哚普利降压方案对复发性中风风险的影响：PROGRESS试验
Stroke. 2004 Jan;35(1):116-21. doi: 10.1161/01.STR.0000106480.76217.6F. Epub 2003 Dec 11.
引用本文的文献
1
2
Blood pressure lowering treatment for preventing stroke recurrence: a systematic review and meta-analysis.降低血压预防卒中复发的治疗：一项系统评价和荟萃分析。
Int Arch Med. 2009 Oct 20;2(1):30. doi: 10.1186/1755-7682-2-30.
3
Delapril plus indapamide: a review of the combination in the treatment of hypertension.地拉普利加吲达帕胺：联合用药治疗高血压的综述
Clin Drug Investig. 2007;27(6):367-80. doi: 10.2165/00044011-200727060-00001.
4
Applicability to primary care of national clinical guidelines on blood pressure lowering for people with stroke: cross sectional study.国家降低卒中患者血压临床指南在初级保健中的适用性：横断面研究
BMJ. 2006 Mar 18;332(7542):635-7. doi: 10.1136/bmj.38758.600116.AE. Epub 2006 Feb 24.
5
Progress in the identification of stroke-related genes: emerging new possibilities to develop concepts in stroke therapy.中风相关基因鉴定的进展：为中风治疗理念的发展带来新的可能性。
CNS Drugs. 2005;19(10):821-32. doi: 10.2165/00023210-200519100-00002.
6
Perindopril monotherapy and PROGRESS in Europe.培哚普利单药治疗与欧洲的PROGRESS研究
BMJ. 2005 Jul 23;331(7510):235-6. doi: 10.1136/bmj.331.7510.235-b.
7
Trial protocols: time for more than tinkering.试验方案：需要的不止是小修小补。
BMJ. 2005 Feb 19;330(7488):421. doi: 10.1136/bmj.330.7488.421-b.
8
Users' guide to detecting misleading claims in research: misleading claims may be symptom of even more serious flaws.研究中误导性主张的检测用户指南：误导性主张可能是更严重缺陷的征兆。
BMJ. 2005 Jan 15;330(7483):145; author reply 146. doi: 10.1136/bmj.330.7483.145.
9
The PROGRESS trial three years later: Clear and accurate interpretations of studies are needed.三年后的PROGRESS试验：需要对研究进行清晰准确的解读。
BMJ. 2004 Dec 11;329(7479):1404. doi: 10.1136/bmj.329.7479.1404.
10
The PROGRESS trial three years later: evangelism is understandable.三年后的PROGRESS试验：传道是可以理解的。
BMJ. 2004 Dec 11;329(7479):1404. doi: 10.1136/bmj.329.7479.1404-a.
本文引用的文献
1
Effects of a perindopril-based blood pressure-lowering regimen on the risk of recurrent stroke according to stroke subtype and medical history: the PROGRESS Trial.根据中风亚型和病史，培哚普利降压方案对复发性中风风险的影响：PROGRESS试验
Stroke. 2004 Jan;35(1):116-21. doi: 10.1161/01.STR.0000106480.76217.6F. Epub 2003 Dec 11.
2
Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials.不同降压方案对主要心血管事件的影响：前瞻性设计的随机试验综述结果
Lancet. 2003 Nov 8;362(9395):1527-35. doi: 10.1016/s0140-6736(03)14739-3.
3
Effects of a perindopril-based blood pressure-lowering regimen on disability and dependency in 6105 patients with cerebrovascular disease: a randomized controlled trial.基于培哚普利的降压方案对6105例脑血管疾病患者残疾和依赖状况的影响：一项随机对照试验
Stroke. 2003 Oct;34(10):2333-8. doi: 10.1161/01.STR.0000091397.81767.40. Epub 2003 Sep 4.
4
Making PROGRESS in stable patients post stroke or transient ischaemic attack: implications for general practice.
Int J Clin Pract. 2003 Jun;57(5):385-7.
5
Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease.培哚普利和吲达帕胺降压治疗对脑血管疾病患者痴呆和认知功能减退的影响。
Arch Intern Med. 2003 May 12;163(9):1069-75. doi: 10.1001/archinte.163.9.1069.
6
Effects of a perindopril-based blood pressure lowering regimen on cardiac outcomes among patients with cerebrovascular disease.基于培哚普利的降压方案对脑血管疾病患者心脏结局的影响。
Eur Heart J. 2003 Mar;24(5):475-84. doi: 10.1016/s0195-668x(02)00804-7.
7
[Control of arterial hypertension in stroke prevention].[预防卒中中的动脉高血压控制]
Klin Med (Mosk). 2002;80(6):53-7.
8
The PROGRESS trial: questions about the effectiveness of angiotensin converting enzyme inhibitors. Perindopril pROtection aGainst REcurrent Stroke Study.
Am J Hypertens. 2002 May;15(5):472-4. doi: 10.1016/s0895-7061(02)02928-x.
9
Does lowering blood pressure prevent recurrent stroke?
Med J Aust. 2002 Mar 18;176(6):283-4. doi: 10.5694/j.1326-5377.2002.tb04410.x.
10
Combined therapy with indapamide and perindopril but not perindopril alone reduced the risk for recurrent stroke.
ACP J Club. 2002 Mar-Apr;136(2):51.
Zotero 插件